Incannex Healthcare INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

29 Sept 2025

IXHL

10-K: Incannex Healthcare Reports FY25 Losses, Advances Drug Pipeline

Incannex Healthcare Inc. reported a significant increase in net loss for fiscal year 2025, driven by financing activities, while advancing its lead drug candidates IHL-42X and PSX-001 through clinical trials.

NASDAQ

30 Sept 2024

IXHL

Incannex Healthcare INC

10-K: Incannex Healthcare Inc. Files 10-K Report, Outlines Clinical Progress and Financials

Incannex Healthcare Inc. released its annual 10-K report, detailing its clinical-stage biopharmaceutical operations, financial status, and future strategies.